Our Pipeline

Program

GI restricted TGF-β inhibitor

Therapeutic Area

Discovery

Development

Hit to lead

Optimization

Preclinic

Phase 1

Phase 2

Crohn´s Disease
Colon Cancer
Lung-restricted TGF-β inhibitor
Idiopathic Pulmonary Fibrosis